Skip to content

Multinational randomized controlled cross-over trial comparing C-brace to conventional knee ankle foot orthoses with respect to balance, fall risk and activities of daily living in patients with lower limb impairment..

Multinational randomized controlled cross-over trial comparing C-brace to conventional knee ankle foot orthoses with respect to balance, fall risk and activities of daily living in patients with lower limb impairment.. - Functional added value of new microprocessor-controlled orthosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON48301
Enrollment
8
Registered
2019-09-18
Start date
2019-10-01
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-polio syndroom, trauma, neurologische aandoeningen zoals multiple sclerose en polyneuropathieen damage to the spinal cord incomplete spinal cord injury

Interventions

A computer-controlled knee-ankle-foot orthosis called a C-Brace, knee-ankle-foot orthosis, dynamic long leg brace.

Sponsors

Otto Bock BV
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Patiënt with an unilateral paresis/paralysis of the lower extremity • Patient is >= 18 years old • Prior active and compliant use of unilateral or bilateral KAFO or SCO in the past 3 months prior to enrollment in the study • Patient has been tested with the Trial Tool (DTO) and demonstrated the potential to utilize the C-Brace successfully • Patient has a BBS score

Exclusion criteria

Exclusion criteria: • Patient who is not using an orthosis at least 1 to 2 hours/ day for 5 days per week • Patient with body weight > 125 kg (includes body weight and heaviest object (weight) carried) • Patient with flexion contracture in the knee and/or hip joint in excess of 10° • Patient with uncontrolled moderate to severe spasticity (relative contraindication moderate spasticity) • Leg length discrepancy in excess of 15 mm Patient with unstable neurological or cardiovascular/pulmonary disease, cancer • Patient is

Design outcomes

Primary

MeasureTime frame
Berg Balance Scale. This is a validated and widely used 14-item scale developed to measure balance in adults.

Secondary

MeasureTime frame
Clinical tests: Dynamic Gait Index (DGI) Stair Assessment Index (SAI) 6-minute walk test Questionnaires: Activity-specific balance confidence (ABC) Scale EQ-5D-5L Medical Outcomes Study Short Form (SF-36) Orthotics & Prosthetics User Survey (OPUS) Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST) Reintegration to Normal Living (RNL) Index questionnaire Work limitations questionnaires WLQ-25

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)